Organization | University of Alberta

University of Alberta Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Edmonton Alberta Canada (1908)

Organization Overview

First Clinical Trial

1994

NCT00002551

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Alternative names

Adrian Wagg | Alberta Diabetes Institute | Alberta Health Services, University of Alberta | Alberta Hospital Edmonton | Alberta Strategy for Patient Oriented Research Support Unit (AbSPORU) | Alberta University | AUIRC/University of Alberta | Bone and Joint Health SCN | Canadian VIGOUR Centre - University of Alberta | CK Hui Heart Centre, Royal Alexandra Hospital, Edmonton, Alberta. | Clinical Islet Transplant Program, University of Alberta | Cross Cancer Institute | Cross Cancer Institute, Alberta Health Services | Cross Cancer Institute at University of Alberta | Cross Cancer Institute, Edmonton AB | Cross Cancer Institute, Edmonton, AB Canada | Cross Cancer Institute, Edmonton, AB, Canada | Cross Cancer Institute, Edmonton Alberta Canada | Cross Cancer Institute, Edmonton, CA | Department of Psychiatry, University of Alberta | Dept. of Medicine, University of Alberta | Dept. of Pediatrics and Pharmacology, University of Alberta | Dina Kao | Division of Community Psychiatry, University of Alberta | Division of Plastic Surgery, Department of Surgery, University of Alberta | Faculty of Rehabilitation Medicine, University of Alberta | Grant Holder, Department of Oncology, University of Alberta | Harald Becher | Ian M. MacDonald | Janielee Williamson | Marcello Tonelli | McCaig Institiute of Bone and Joint Health | McCaig Institute for Bone and Joint Health | Professor of Endocrinology and Oncology, University of Alberta, Cross Cancer Institute | Professor, University of Alberta | Prof. Philip Halloran, Edmonton, Canada | Prof. Philip Halloran, Edmonton, Canada (sponsor) | Richard Fedorak | Robert Welsh | Staff Medical Oncologist, Cross Cancer Institute, Department of Medical Oncology, Edmonton, AB | Stollery Children's Hospital | Stollery Children's Hospital and the University of Alberta | Stollery Children's Hospital Edmonton | Stollery Children's Hospital Foundation | The Governors of the University of Alberta | Univeristy of Alberta | University Hospital Foundation | University of Alberta | University Of Alberta, Alberta, Canada | University of Alberta and Capital Health | University of Alberta/Capital Health | University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada | University of Alberta, Division of Gastroenterology, Department of Medicine, Edmonton, Alberta, Canada | University of Alberta, Edmonton | University of Alberta, Edmonton, Canada | University of Alberta Hospital, AB | University of Alberta Hospital, Edmonton, Canada | University of Alberta/Regional Palliatvie Care Program (Capital Health) | University of Alberta/Stollery Children's Hospital | Unviersity of Alberta | U of Alberta Co-Director,Perio Graduate Prog,Faculty of Medicine & Dentistry-Dentistry Dept | Women and Children's Health Research Institute, University of Alberta, Edmonton | Women and Children's Health Research Institute, Univesrity of Alberta | Xiaoli Fan

University of Alberta Report issue

Drugs in Phase 4 Trials (59)

Drugs in Phase 3 Trials (101)

Drugs in Phase 2 Trials (108)

Drugs in Phase 1 Trials (23)

Drugs in Other Trials (43)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview